SEC Company Response from Imunon, Inc. (IMNN) (CIK 0000749647) (IMNN) — Feb 13, 2017
Imunon, Inc. (IMNN) (CIK 0000749647)
Date: Feb. 13, 2017 · CIK: 0000749647 · Accession: 0001437749-17-002222
AI Filing Summary & Sentiment
File numbers found in text: 333-215321
Show Raw Text
CORRESP 1 filename1.htm clsn20170213_corresp.htm Celsion Corporation 997 Lenox Dr., Suite 100 Lawrenceville, New Jersey 08648 February 13, 2017 VIA EDGAR Division of Corporation Finance Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Attention: Joseph McCann Re: Celsion Corporation Registration Statement on Form S-1 Filed February 13, 2017 (File No. 333-215321) Dear Mr. McCann: Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Celsion Corporation, a Delaware corporation (the “Registrant”), hereby requests that the effectiveness of the registration statement on Form S-1 (File No. 333-215321), as amended by Pre-Effective Amendment No. 1 as filed with the Securities and Exchange Commission (“SEC”) on January 20, 2017, and as further amended by Pre-Effective Amendments Nos. 2 and 3 as filed with the SEC on the date hereof, be accelerated so that the registration statement becomes effective at 5:00 p.m. Eastern Time, on February 14, 2017, or as soon thereafter as practicable. If you have any questions or require any additional information with respect to any of the matters discussed in this letter, please contact Sam Zucker of Sidley Austin LLP, counsel to the Registrant, at (650) 565-7111. Very truly yours, Celsion Corporation By: /s/ Jeffrey W. Church Jeffrey W. Church Senior Vice President and Chief Financial Officer (Principal Financial Officer) cc: Michael H. Tardugno, Chairman of the Board, President and Chief Executive Officer, Celsion Corporation Sam Zucker, Sidley Austin LLP